"La Fundación Instituto Valenciano de Oncología (IVO), es un centro monográfico especializado en la asistencia al paciente con cáncer. El IVO es una entidad privada sin ánimo de lucro, cuyos patrimonio y recursos se destinan íntegramente a la lucha contra el cáncer en todas sus vertientes: prevención, diagnóstico, tratamiento, investigación y docencia."

During the past decade, Instituto Valenciano de Oncología conducted 172 clinical trials. In the 10-year time frame, 172 clinical trials started and 74 clinical trials were completed, i.e. on average, 43% percent of trials that started reached the finish line to date. In the past 5 years, 70 clinical trials started and 53 clinical trials were completed. i.e. 75.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Instituto Valenciano de Oncología" #1 sponsor was "Hoffmann-La Roche" with 24 trials, followed by "Spanish Breast Cancer Research Group" with 20 trials sponsored, "Pfizer" with 15 trials sponsored, "Spanish Oncology Genito-Urinary Group" with 15 trials sponsored and "SOLTI Breast Cancer Research Group" with 15 trials sponsored. Other sponsors include 178 different institutions and companies that sponsored additional 99 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto Valenciano de Oncología" #1 collaborator was "AstraZeneca" with 14 trials as a collaborator, "Pfizer" with 11 trials as a collaborator, "Apices Soluciones S.L." with 9 trials as a collaborator, "Hoffmann-La Roche" with 9 trials as a collaborator and "Bristol-Myers Squibb" with 7 trials as a collaborator. Other collaborators include 185 different institutions and companies that were collaborators in the rest 133 trials.

According to Clinical.Site data, the most researched conditions in "Instituto Valenciano de Oncología" are "Breast Cancer" (48 trials), "Ovarian Cancer" (14 trials), "Metastatic Breast Cancer" (11 trials), "Prostate Cancer" (11 trials) and "Melanoma" (8 trials). Many other conditions were trialed in "Instituto Valenciano de Oncología" in a lesser frequency.

Most popular intervention types in "Instituto Valenciano de Oncología" are "Drug" (232 trials), "Other" (19 trials), "Procedure" (15 trials), "Biological" (14 trials) and "Radiation" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (21 trials), "Paclitaxel" (18 trials), "Carboplatin" (12 trials), "Trastuzumab" (12 trials) and "Capecitabine" (10 trials). Other intervention names were less common.

The vast majority of trials in "Instituto Valenciano de Oncología" are 163 trials for "All" genders, 74 trials for "Female" genders and 33 trials for "Male" genders.

Currently, there are NaN active trials in "Instituto Valenciano de Oncología". undefined are not yet recruiting, 49 are recruiting, 53 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 135 completed trials in Instituto Valenciano de Oncología, 1 suspended trials, and 19 terminated clinical trials to date.

Out of the total trials that were conducted in Instituto Valenciano de Oncología, 21 "Phase 1" clinical trials were conducted, 108 "Phase 2" clinical trials and 105 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 7 trials that are defined as “Not Applicable".